Alec Machiels - Dec 15, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Stock symbol
APLS
Transactions as of
Dec 15, 2021
Transactions value $
-$120,630
Form type
4
Date filed
12/17/2021, 04:09 PM
Previous filing
Nov 17, 2021
Next filing
Feb 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $8.01K +3K +0.45% $2.67* 673K Dec 15, 2021 Direct F1
transaction APLS Common Stock Sale -$129K -3K -0.45% $42.88 670K Dec 15, 2021 Direct F1
holding APLS Common Stock 1.95K Dec 15, 2021 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -3K -2.28% $0.00 129K Dec 15, 2021 Common Stock 3K $2.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise and sale from 10B5-1 trading plan.
F2 Owned by spouse.
F3 This option was granted on December 5, 2013 and fully vested.